TSE:CRON Cronos Group (CRON) Stock Price, News & Analysis → Biden replacement revealed? (From Paradigm Press) (Ad) Free CRON Stock Alerts C$3.38 -0.05 (-1.46%) (As of 06/7/2024 08:53 PM ET) Add Compare Share Share Today's RangeC$3.35▼C$3.4350-Day RangeC$3.22▼C$4.1452-Week RangeC$2.15▼C$4.28Volume102,541 shsAverage Volume214,354 shsMarket CapitalizationC$1.29 billionP/E RatioN/ADividend YieldN/APrice TargetC$3.18 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlines Get Cronos Group alerts: Email Address Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. About Cronos Group Stock (TSE:CRON)Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.Read More CRON Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CRON Stock News HeadlinesMay 28, 2024 | finance.yahoo.comCronos Group Fluctuating in U.S. After Hours As Terminates Sale-Leaseback of Peace Naturals CampusMay 10, 2024 | finance.yahoo.comCronos Group Inc. (NASDAQ:CRON) Q1 2024 Earnings Call TranscriptMay 9, 2024 | marketwatch.comCronos 1Q Revenue Rises on Gains in Canada, IsraelMay 7, 2024 | msn.comCanadian Marijuana Company Cronos Expands Into UK After Setting Up In Germany's Nascent MarketMay 1, 2024 | benzinga.comBehind the Scenes of Altria Group's Latest Options TrendsMay 1, 2024 | msn.comUS moves to reclassify marijuana as low-risk drug, sparks surge in cannabis stocksApril 26, 2024 | msn.comChinese Financial Services Shares Gain on Consolidation HopesApril 21, 2024 | finance.yahoo.comSannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage EffectApril 19, 2024 | finance.yahoo.comCronos Group Inc.'s (TSE:CRON) Shift From Loss To ProfitApril 18, 2024 | investing.comKPMG to exit cannabis industry audits, Cronos seeks new firmMarch 25, 2024 | finance.yahoo.comCronos Group Inc. Ontario Securities Class Action NoticeMarch 18, 2024 | msn.com1 High-Yield Dividend King to Scoop Up While It's CheapMarch 16, 2024 | finance.yahoo.comCRON Oct 2024 2.500 putMarch 15, 2024 | benzinga.comSmart Money Is Betting Big In Altria Group OptionsMarch 1, 2024 | finance.yahoo.comCronos Group Inc. (NASDAQ:CRON) Q4 2023 Earnings Call TranscriptFebruary 20, 2024 | msn.comLaw enforcement agencies disrupt prolific ransomware group LockBitFebruary 19, 2024 | msn.comLockbit cybercrime gang disrupted by international police operationFebruary 19, 2024 | msn.comLockBit ransomware gang disrupted by global operationFebruary 15, 2024 | msn.comThe highs and lows of yeast-derived cannabisFebruary 15, 2024 | msn.comEni drills second well at Cronos gas discovery off CyprusFebruary 15, 2024 | msn.com‘Excellent’ Cronos gas discovery off CyprusFebruary 14, 2024 | finance.yahoo.comCronos Group Inc. to Hold 2023 Fourth Quarter and Full-Year Earnings Conference Call on February 29, 2024February 13, 2024 | morningstar.comCronos Group Inc CRONFebruary 5, 2024 | investing.comCronos Group Inc (CRON)February 3, 2024 | finance.yahoo.comWhile public companies own 41% of Cronos Group Inc. (TSE:CRON), retail investors are its largest shareholders with 44% ownershipSee More Headlines Receive CRON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolTSE:CRON CUSIPN/A CIKN/A Webwww.thecronosgroup.com Phone416-504-0004FaxN/AEmployees356Year FoundedN/APrice Target and Rating Average Stock Price TargetC$3.18 High Stock Price TargetC$3.54 Low Stock Price TargetC$2.82 Potential Upside/Downside-5.9%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.19) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth0.12Net IncomeC$-54,140,000.00 Net Margins-61.31% Pretax MarginN/A Return on Equity-4.99% Return on Assets-4.02% Debt Debt-to-Equity Ratio0.21 Current Ratio28.19 Quick Ratio24.01 Sales & Book Value Annual SalesC$93.03 million Price / Sales13.88 Cash FlowC$2.02 per share Price / Cash Flow1.67 Book ValueC$2.82 per share Price / Book1.20Miscellaneous Outstanding Shares382,010,000Free FloatN/AMarket CapC$1.29 billion OptionableNot Optionable Beta1.08 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Michael Ryan Gorenstein J.D. (Age 37)President, CEO & Chairman Comp: $5.38MMr. James Holm (Age 41)Chief Financial Officer Comp: $429.32kMr. Jeffrey David Jacobson (Age 38)Chief Growth Officer Comp: $997.28kMs. Anna Shlimak (Age 38)Senior Vice President of Corporate Affairs & Strategy Comp: $724.62kMr. James Andrew McGinness III (Age 45)VP, Controller & Principal Accounting Officer Mr. Shayne J. LaidlawDirector of Investor Relations & StrategyMr. Terry Gregory-Joseph Doucet (Age 34)General Counsel & Corporate Secretary Ms. Shannon Buggy (Age 54)Senior VP & Global Head of People Comp: $599.38kMr. Arye Weigensberg (Age 41)Senior VP & Head of Research and Development Mr. Adam WagnerSenior VP & Head of Cronos IsraelMore ExecutivesKey CompetitorsBausch Health CompaniesTSE:BHCTilray BrandsTSE:TLRYHydropothecaryCVE:THCXCanopy GrowthTSE:WEEDKnight TherapeuticsTSE:GUDView All Competitors CRON Stock Analysis - Frequently Asked Questions Should I buy or sell Cronos Group stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CRON shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRON, but not buy additional shares or sell existing shares. View CRON analyst ratings or view top-rated stocks. What is Cronos Group's stock price target for 2024? 2 brokerages have issued 12 month price targets for Cronos Group's shares. Their CRON share price targets range from C$2.82 to C$3.54. On average, they expect the company's stock price to reach C$3.18 in the next twelve months. This suggests that the stock has a possible downside of 5.9%. View analysts price targets for CRON or view top-rated stocks among Wall Street analysts. How have CRON shares performed in 2024? Cronos Group's stock was trading at C$2.77 at the beginning of the year. Since then, CRON shares have increased by 22.0% and is now trading at C$3.38. View the best growth stocks for 2024 here. What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), NVIDIA (NVDA), Aphria (APHA), Advanced Micro Devices (AMD), Netflix (NFLX), Walt Disney (DIS) and Intel (INTC). How do I buy shares of Cronos Group? Shares of CRON stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:CRON) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredNvidia needs this one obscure firm In my new investigation, I detail why this is the single most important factor in the future of AI. I expla...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cronos Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.